Tech Company Financing Transactions
BioMotiv Funding Round
On 9/30/2015, BioMotiv secured $30.5 million in funding from Takeda Ventures.
Transaction Overview
Company Name
Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
$30,450,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20600 Chagrin Blvd. 210
Cleveland, OH 44122
USA
Cleveland, OH 44122
USA
Phone
Website
Email Address
Overview
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Theodore Torphy
Chief Financial Officer
Mark Teague
Chief Medical Officer
Jeffrey Edelson
Chief Technical Officer
Charles McOsker
Browse more venture capital transactions:
Prev: 9/30/2015: Tenant Turner venture capital transaction
Next: 9/30/2015: Vivoom venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs